AJR 2002; 178:1349-1352
© American Roentgen Ray Society
MR Safety and the American College of Radiology White Paper
Frank G. Shellock1,2 and
John V. Crues, III3
1 Institute for Magnetic Resonance Safety, Education, and Research, Los Angeles,
CA 90045.
2 Department of Radiology, University of Southern California, 7511 McConnell
Ave., Los Angeles, CA 90045.
3 Radnet, Los Angeles, CA 90048.
Received March 25, 2002;
accepted after revision March 25, 2002.
This article is a commentary on the preceding article by Kanal et al.
Address correspondence to F. G. Shellock.
Introduction
As long-time, active members of the American College of Radiology (ACR), we
are pleased to offer commentary on the "American College of Radiology
White Paper on MR Safety"
[1], a document that "is
intended to be used as a template for MR facilities to follow in the
development of an MR safety program." As such, it should be noted that
these are not actual rules but, rather, recommendations that may be
implemented or modified by the MR facility on the basis of its specific
requirements (notably, the ACR White Paper was approved by the ACR leadership
but does not carry the same meaning as an ACR standard that has gone through
the consensus process).
Since the introduction of MR imaging as a clinical modality in the early
1980s, an enormous number of diagnostic proceduresestimated to be more
than 100 millionhave been completed with relatively few major incidents
[2,3,4,5,6,7,8,9,10].
The few serious injuries or deaths that have occurred have been mostly
attributed to the inadvertent presence of ferromagnetic implants or objects
(e.g., ferromagnetic aneurysm clip, oxygen tank) and cardiac pacemakers
[8,
9,
11,
12].
The topic of safety in the MR environment has long merited attention. A
conservative estimate of the medical literature pertaining to MR safety and
bioeffects indicates that more than 250 peer-reviewed articles have been
published to date. Additionally, there are at least three recently published
textbooks [4,
6,
9] and two Web sites
(www.MRIsafety.com
[13] and
www.radiology.upmc.edu/MRsafety/
[14]) devoted to MR safety.
Unfortunately, it took the tragic loss of a child's life in a New York
hospital to bring the topic of MR safety the current notoriety that it
rightfully deserves [11,
12].
The first contributions by organized radiology to provide MR safety
guidelines and recommendations to the MR community occurred in 1991 and
continued until 1994
[15,16,17].
Unfortunately, additional documents have not been forthcoming from MR
specialty or other professional organizations despite the continuing worldwide
proliferation of MR systems. Therefore, it is particularly timely for the ACR
to formally contribute to the field of MR safety, and we applaud and support
this important effort.
After carefully reviewing the "American College of Radiology White
Paper on MR Safety," we identified several critical areas that require
further consideration. Therefore, we respectfully offer a point-by-point
discussion of several aspects of the ACR White Paper with the intent of
clarifying the recommendations or, in some cases, offering a differing
viewpoint based on our 17 years of experience and the available peer-reviewed
literature.
Overall Recommendations
The ACR's MR safety recommendations evidently apply to conventional
clinical MR systems, not to specialized MR systems (e.g., dedicated extremity
MR systems, niche MR systems, and interventional MR systems) or those used
predominantly for research (e.g., with magnetic field strengths from 3.0 to
8.0 T). This important aspect of the recommended policies and procedures
should be emphasized from the onset to avoid confusion or misinterpretation of
the information. Obviously, the basic premises discussed in this ACR White
Paper may apply to MR facilities that use specialized MR systems, but they
need to be substantially modified in consideration of the unique requirements
of unconventional scanners.
The ACR White Paper indicates that the medical director should be primarily
responsible for the MR-safety training program. We believe that the value of
this ACR White Paper would be markedly enhanced if it would provide guidance
regarding the qualifications for the medical director and specific training
curricula for the MR technologists and other staff members, especially for MR
facilities that are not under the control of formally trained MR
radiologists.
Zoning
The concept of designating various zones to help control site access
relative to the static magnetic field of the MR system, although interesting,
has no precedent in the MR imaging literature nor empiric support for its
usefulness in preventing MR imagingrelated accidents. Importantly, the
zoning of the MR environment as proposed in the ACR White Paper is not
intuitive and, thus, may be confusing to MR personnel and others (e.g., why is
zone IV "synonymous with the MR scanner magnet room"?) or
impractical to implement. It is essential to know what upper limit of the
magnetic fringe field corresponds to the various zones proposed in the ACR
White Paper because this limit will influence the recommendations provided.
Furthermore, the zone associated with the operational aspect of the MR system
(i.e., within the bore) should be considered because this area directly
impacts MR safety. Therefore, we recommend that the zone associated within the
MR system itself be considered because it is the most important zone of the MR
environment. Zones removed from the MR system should be designated on the
basis of the relative importance to the specific MR system (e.g., adjusted on
the basis of MR system field strength and other considerations). Notably, the
so-called zone IV area is not as potentially hazardous for a shielded 0.2-T MR
system as it is for an unshielded 1.5-T MR system; therefore, the MR site will
need to adjust policies and procedures on the basis of its specific MR
environment.
Patient and Nonpersonnel Screening
We disagree with the ACR White Paper's suggestion that nonemergent patients
should be screened by "a minimum of two separate individuals" and
that emergent patients may be screened only once. (Why isn't it sufficient for
nonemergent and emergent patients to undergo thorough screening by a level II
individual?) In fact, in the clinical MR setting, it is uncommon and probably
unnecessary for a patient to be screened by two different individuals,
especially if the screening process is thorough and involves written and
verbal evaluations [7,
17]. This important topic was
the subject of recent extensive review that included comprehensive guidelines
and a thorough MR screening form
[7]; this form can be
downloaded from
www.MRIsafety.com
[13].
Implants, Devices, Objects: MR Safety and MR Compatibility
The ACR White Paper tends to use the terms "MR safety [safe]"
and "MR compatibility [compatible]" individually as well as
interchangeably without defining these terms or providing a supporting
reference, which causes undue confusion. For those in the MR imaging community
who are unfamiliar with these terms, they are defined as follows
[18].
MR-safe means that the device, when used in the MR environment, has been
shown to present no additional risk to the patient or other individual but may
affect the quality of the diagnostic information. The MR conditions in which
the device was tested should be specified in conjunction with the term
"MR-safe" because a device that is safe under one set of
conditions may not be safe in more extreme MR conditions.
A device is considered "MR-compatible" if it is MR-safe and if
it has been shown to neither significantly affect the quality of the
diagnostic information nor have its operations affected by the MR device when
used in the MR environment. The MR conditions in which the device was tested
should be specified in conjunction with the term "MR-compatible"
because a device that is compatible under one set of conditions may not be
compatible under more extreme MR conditions.
MR-safety testing of an implant or object involves assessment of magnetic
field interactions, heating, and induced electric currents while
MR-compatibility testing requires all of these as well as the characterization
of artifacts [1,
4,
5,
15,16,17,18,19,20].
Additionally, the operation or function of the device is evaluated for
MR-compatibilty testing.
Monitoring Patients
Monitoring patients during MR procedures has been the subject of several
reviews and book chapters
[25,26,27,28].
Currently, a variety of MR-compatible monitoring devices (labeled as having
been approved by the United States Food and Drug Administration [FDA]) are
commercially available to record virtually every important physiologic
parameter [5,
6,
9,
25,26,27,28],
including one that records the ECG using fiberoptic technology (thus, removing
the concern of thermal injury stated in the ACR White Paper).
The improper use of ECG recording equipment has been reported to cause
thermal injuries, but this type of injury has occurred in a relatively small
number of patients [5,
6,
9,
10,
25,26,27,28].
Therefore, the ACR White Paper appears to overemphasize this issue, especially
in consideration of the fact that guidelines to prevent such injuries have
been previously published [5,
6,
9,
25,26,27,28,29,30].
We suggest that MR health care professionals review the prior recommendations
and implement a strategy to prevent possible patient burns as part of their
MR-safety policies and procedures.
Device and Object Screening
The ACR White Paper recommends that the MR facility have a strong (>1000
G) handheld magnet available for testing and clearing external and even
superficial internal devices or implants. This recommendation greatly
over-simplifies MR-safety testing of implants and devices because it does not
consider other crucial aspects of MR safety (stated earlier) and, importantly,
because there is no published evidence to support the sensitivity or
usefulness of this procedure (particularly for identifying superficial
implanted devices).
For example, a problem could occur using the handheld magnet to
"clear" an external fixation device (nonmagnetic but made from
conductive metal) that could realistically pose a hazard to a patient
undergoing MR imaging. Additionally, in our opinion, MR health care
professionals may not want to be responsible for MR testing of equipment and
implants, nor is this really necessary. Many commercially available patient
support devices and accessories have already undergone such evaluation (which
are designated as MR-safe or MR-compatible using red labels), and there is
MR-safety or MR-compatibility information available for more than 950 implants
[4,
6]. This information is readily
available online to all MR users
[13].
Furthermore, various accessories made with ferromagnetic components have
labeling approved by the FDA that permits them to be used in zone IV (i.e., in
the MR system room) as long as they are specifically positioned relative to
the fringe field (e.g., not to exceed 200 G) and are anchored or fixed in
position. This conflicts with the information in the ACR White Paper.
Labeling of Devices by MR Personnel
The ACR White Paper indicates that MR personnel should label
"approved" devices with a green label and "unapproved"
devices with a red label. Unfortunately, this recommendation conflicts with
labeling that already exists for many devices (stated earlier). This issue is
likely to cause confusion; therefore, we urge the ACR to reconsider this
matter and to be consistent with current labeling for commercially available
MR-safe and MR-compatible devices and accessories.
MR-Safe Practice Guidelines and the MR Technologist
The suggestions of the ACR White Paper to have only technologists who have
been certified by the American Registry of Radiologic Technologists (ARRT)
(should they also be MR-certified within the ARRT?) performing MR imaging and
to have at least two individuals present during routine MR procedures is
impractical and unrealistic given the present shortage of MR technologists and
personnel (which is unlikely to change in the foreseeable future). Many sites
in the United States have highly capable MR technologists performing MR
imaging who are not ARRT-registered.
Auditory Considerations
A recent comprehensive review was published on the topic of auditory
considerations in the MR environment
[31]. In general, acoustic
noise may be problematic only for MR systems operating above 0.5-T or during
the use of pulse sequences that use small fields of view, thin sections, short
TRs, and short TEs [31,
32]. However, the ACR White
Paper makes general statements about auditory considerations, suggesting that
all patients and volunteers should use ear protection, without acknowledging
the factors responsible for excessive acoustic noise or recommending a decibel
level that represents a potentially hazardous threshold. In addition to
auditory considerations for patients, the exposure of staff and other health
care workers in the MR environment is of concern
[31,
32]. Therefore, we also
recommend that earplugs or other hearing protection be worm by health care
workers and other individuals who may need to remain in the room (e.g., those
involved in interventional MR procedures or who remain in the room for patient
treatment reasons) during the operation of MR systems that generate excessive
acoustic noise [31,
32].
Time-Varying Radiofrequency Magnetic Field-Related Issues
(Thermal)
The various recommendations in the ACR White Paper to prevent thermal
injuries have been previously reported in the peer-reviewed literature and
elsewhere [5,
6,
9,
30]. We believe that it is
appropriate to acknowledge the original source of these guidelines.
Skin Staples and Superficial Metallic Sutures
The recommendation that patients with skin staples or superficial metallic
sutures have a cold compress or ice pack applied to serve as a "heat
sink" and decrease the likelihood of a significant thermal injury or
burn is surprising. Many investigations have reported that little or no
heating occurs for small implants (e.g., clips, wires) even if they form
conductive loops, which are inherently small
[4,
33,34,35].
In addition, there is no report in the peer-reviewed literature that we are
aware of that heating of staples or sutures caused a patient injury or that
application of a cold compress or ice pack could prevent such an injury.
MR Imaging and Tattoos
Excessive heating of tattoos rarely occurs in patients undergoing MR
procedures and has been reported only in cases involving the use of iron oxide
for the tattoo pigment
[36,37,38,39,40].
Therefore, the general recommendation of using cold compresses or ice packs
for all patients with tattoos is not supported by the medical literature.
Claustrophobia and Anxiety
The ACR White Paper provides no recommendations regarding the management of
patients with claustrophobia, anxiety, or emotional distress associated with
MR imaging other than commenting about the use of medications. This is an
oversight because in many instances patients with these problems may be able
to undergo MR procedures without being medicated if the MR health care
professionals recognize and implement appropriate strategies to manage these
cases [5,
6,
41]. Therefore, we encourage
MR facilities to include recommended techniques for managing patients with
claustrophobia, anxiety, or emotional distress related to MR procedures in
their policies and procedures (Appendix 1).
MR Procedures and Patients with Aneurysm Clips
The ACR White Paper provides extensive guidelines regarding performing MR
procedures in patients with aneurysm clips. This information is especially
useful because of the confusion and controversy regarding this matter. Similar
recommendations have appeared several times in the literature
[4,
6,
7,
9,
42,43,44,45].
Concluding Remarks
Maintaining a safe MR environment is a daily challenge and a crucial
responsibility for all MR health care professionals. We respectfully
acknowledge the work of the ACR's Blue Ribbon Task Force on Patient Safety. We
encourage the MR community to create or update their policies and procedures
pertaining to MR safety on the basis of this information as well as the
findings in the relevant medical literature. Additional consideration should
also be given to the points we raised in our commentary.
View this table:
[in this window]
[in a new window]
|
APPENDIX 1. Recommended Techniques for Managing Patients with Claustrophobia,
Anxiety, or Emotional Distress Related to MR Procedures
|
|
References
-
Kanal E, Borgstede JP, Barkovich AJ, et al. American College of
Radiology white paper on MR safety. AJR
2002;178:1335
-1347[Free Full Text]
-
New PFJ, Rosen BR, Brady TJ, et al. Potential hazards and artifacts
of ferromagnetic and non-ferromagnetic surgical and dental materials and
devices in nuclear magnetic resonance imaging.
Radiology
1983;147:139
-148[Abstract/Free Full Text]
-
Shellock FG, Crues JV. High-field-strength MR imaging and metallic
biomedical implants: an ex vivo evaluation of deflection forces.
AJR
1988;151:389
-392[Abstract/Free Full Text]
-
Shellock FG. Pocket guide to metallic implants and MR
procedures: update 2000, 7th ed. New York: Lippincott-Raven
Healthcare, 2001:1
-159
-
Shellock FG, Kanal E. Magnetic resonance: bio-effects,
safety, and patient management, 2nd ed. New York:
Lippincott-Raven, 1996
-
Shellock FG. Reference manual for magnetic resonance
safety: 2002 edition. Salt Lake City: Amirsys,
2002
-
Sawyer-Glover A, Shellock FG. Pre-MRI procedure screening:
recommendations and safety considerations for biomedical implants and devices.
J Magn Reson Imaging
2000;12:92
-106[Medline]
-
Schenck JF. Health effects and safety of static magnetic fields.
In: Shellock FG, ed. Magnetic resonance procedures: health effects
and safety. Boca Raton, FL: CRC, 2001:1
-31
-
Shellock FG. Magnetic resonance procedures: health
effects and safety. Boca Raton, FL: CRC,
2001
-
Medical device report [database online]. Washington, DC:Center for Devices and Radiological Health
, U.S. Food and Drug
Administration, Mar 4, 2002. Updated monthly
-
Kerr JD. MRI safety: everyone's job. Radiol
Manage 2001;23:36
-39
-
ECRI hazard report: patient death illustrates the importance of
adhering to safety precautions in magnetic resonance environments.
Health Devices
2001;30:311
-314[Medline]
-
MRIsafety.com
. Available at:
www.MRIsafety.com
. Accessed April 5, 2002
-
Magnetic resonance safety site. Available at:
www.radiology.upmc.edu/MRsafety/
. Accessed April 5, 2002
-
Shellock FG, Kanal E. Policies, guidelines, and recommendations for
MR imaging safety and patient management. J Magn Reson
Imaging 1991;1:97
-101[Medline]
-
Kanal E, Shellock FG. Policies, guidelines, and recommendations for
MR imaging safety and patient management: patient monitoring during MR
examinations. J Magn Reson Imaging
1992;2:247
-248[Medline]
-
Shellock FG, Kanal E. Guidelines and recommendations for MR imaging
safety and patient management. III. Questionnaire for screening patients
before MR procedures. J Magn Reson Imaging
1994;4:749
-751[Medline]
-
American Society for Testing and Materials. Standard test method
for measurement of magnetically induced displacement force on passive implants
in the magnetic resonance environment. In: Annual book of ASTM
standards. West Conshohocken, PA: American Society for Testing
and Materials, 2001: 1576-1580
(section 13, vol. 13.01, designation F
2052)
-
Kangarlu A, Shellock FG. Aneurysm clips: evaluation of magnetic
field interactions with an 8.0 T MR system. J Magn Reson
Imaging 2000;12:107
-111[Medline]
-
Rezai AR, Finelli D, Nyenhuis JA, et al. Neurostimulator for deep
brain stimulation: ex vivo evaluation of MRI-related heating at 1.5-Tesla.
J Magn Reson Imaging
2002;15:141
-150
-
Shellock FG, Shellock VJ. Vascular access ports and catheters
tested for ferromagnetism, heating, and artifacts associated with MR imaging.
Magn Reson Imaging
1996;14:443
-447[Medline]
-
Shellock FG, Detrick MS, Brant-Zawadski M. MR-compatibility of
Guglielmi detachable coils. Radiology
1997;203:568
-570[Abstract/Free Full Text]
-
Shellock FG, Shellock VJ. MR-compatibility evaluation of the
Spetzler titanium aneurysm clip. Radiology
1998;206:838
-841[Abstract/Free Full Text]
-
Shellock FG, Shellock VJ. Evaluation of cranial flap fixation
clamps for compatibility with MR imaging. Radiology
1998;207:822
-825[Abstract/Free Full Text]
-
Kanal E, Shellock FG. Patient monitoring during clinical MR
imaging. Radiology
1992;185:623
-629[Abstract/Free Full Text]
-
Holshouser B, Hinshaw DB, Shellock FG. Sedation, anesthesia, and
physiologic monitoring during MRI. J Magn Reson
Imaging 1993;3:553
-558[Medline]
-
Shellock FG. Magnetic resonance safety: recommendations and
guidelines for pre-procedure screening. In: Special cross-specialty
categorical course in diagnostic radiology: practical MR safety considerations
for physicians, physicists, and technologists. Oak Brook, IL:
Radiological Society of North America, 2001:33
-39
-
Shellock FG. Safety, bioeffects, and patient monitoring. In:
Gronemeyer H, Lufkin R, Seibel J, eds. Open-field MRI.
Heidelberg, Germany: Springer-Verlag, 1998:14
-29
-
Kanal E, Shellock FG. Burns associated with clinical MR
examinations. (letter) Radiology
1990;175:585[Free Full Text]
-
Shellock FG, Kanal E. Burns associated with the use of monitoring
equipment during MR procedures. J Magn Reson Imaging
1996;6:271
-272[Medline]
-
McJury M, Shellock FG. Acoustic noise and MR procedures: a review.
J Magn Reson Imaging
2000;12:37
-45[Medline]
-
Shellock FG, Ziarati M, Atkinson D, Chen DY. Determination of
gradient magnetic field-induced acoustic noise associated with the use of echo
planar and three-dimensional, fast spin echo techniques. J Magn
Reson Imaging 1998;8:1154
-1157[Medline]
-
Davis PL, Crooks L, Arakawa M, McRee R, Kaufman L, Margulis AR.
Potential hazards in NMR imaging: heating effects of changing magnetic fields
and RF fields on small metallic implants. AJR
1981;137:857
-860[Abstract/Free Full Text]
-
Shellock FG. Metallic marking clips used after stereotactic breast
biopsy: ex vivo testing of ferromagnetism, heating, and artifacts associated
with MR imaging. AJR
1999;172:1417
-1419[Free Full Text]
-
Shellock FG. Metallic neurosurgical implants: evaluation of
magnetic field interactions, heating, and artifacts at 1.5 Tesla. J
Magn Reson Imaging
2001;14:295
-299[Medline]
-
Tope WD, Shellock FG. Magnetic resonance imaging and permanent
cosmetics tattoos: survey of complications and adverse events. J
Magn Reson Imaging
2002;15:180
-184[Medline]
-
Carr JJ. Danger in performing MR imaging on women who have tattooed
eyeliner or similar types of permanent cosmetic injections.
AJR
1995;165:1546
-1547[Medline]
-
Kreidstein ML, Giguere D, Freiberg A. MRI interaction with tattoo
pigments: case report, pathophysiology, and management. Plast
Reconstr Surg 1997;99:1717
-1720[Medline]
-
Wagle WA, Smith M. Tattoo-induced skin burn during MR imaging.
(letter) AJR
2000;174:1795[Free Full Text]
-
Vahlensieck M. Tattoo-related cutaneous inflammation burn grade I
in a mid-field MR scanner. (letter) Eur Radiol
2000;10:97
-
Gollub R, Shellock FG. Claustrophobia, anxiety and emotional
distress. In: Shellock FG, ed. Magnetic resonance procedures:
health effects and safety. Boca Raton, FL: CRC,
2001: 197-216
-
Shellock FG, Kanal E. Yasargil aneurysm clips: evaluation of
interactions with a 1.5 Tesla MR system. Radiology
1998;207:587
-591[Abstract/Free Full Text]
-
Kanal E, Shellock FG. Aneurysm clips: effects of long-term and
multiple exposures to a 1.5 Tesla MR system. Radiology
1999;210:563
-565[Abstract/Free Full Text]
-
Shellock FG. Patient monitoring in the MR environment. In:
Special cross-specialty categorical course in diagnostic radiology:
practical MR safety considerations for physicians, physicists, and
technologists. Oak Brook, IL: Radiological Society of North
America, 2001: 40-48
-
Pride GL, Kowal J, Mendelsohn DB, Chason DP, Fleckenstein JL.
Safety of MR scanning in patients with nonferromagnetic aneurysm clips.
J Magn Reson Imaging
2000;12:198
-200[Medline]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. G. Shellock, T. O. Woods, and J. V. Crues III
MR Labeling Information for Implants and Devices: Explanation of Terminology
Radiology,
October 1, 2009;
253(1):
26 - 30.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. G. Shellock and A. Spinazzi
MRI Safety Update 2008: Part 2, Screening Patients for MRI
Am. J. Roentgenol.,
October 1, 2008;
191(4):
1140 - 1149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Roguin, J. Schwitter, C. Vahlhaus, M. Lombardi, J. Brugada, P. Vardas, A. Auricchio, S. Priori, and T. Sommer
Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices
Europace,
March 1, 2008;
10(3):
336 - 346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. N. Levine, A. S. Gomes, A. E. Arai, D. A. Bluemke, S. D. Flamm, E. Kanal, W. J. Manning, E. T. Martin, J. M. Smith, N. Wilke, et al.
Safety of Magnetic Resonance Imaging in Patients With Cardiovascular Devices: An American Heart Association Scientific Statement From the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: Endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance
Circulation,
December 11, 2007;
116(24):
2878 - 2891.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Muhler
Can Intrauterine Devices Actually Be Considered Safe at 3-T MR Imaging?
Radiology,
May 1, 2005;
235(2):
709 - 709.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. G. Shellock, M. Gounis, and A. Wakhloo
Detachable Coil for Cerebral Aneurysms: In Vitro Evaluation of Magnetic Field Interactions, Heating, and Artifacts at 3T
AJNR Am. J. Neuroradiol.,
February 1, 2005;
26(2):
363 - 366.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Loewy, A. Loewy, and E. J. Kendall
Reconsideration of Pacemakers and MR Imaging
RadioGraphics,
September 1, 2004;
24(5):
1257 - 1267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Roguin, M. M. Zviman, G. R. Meininger, E. R. Rodrigues, T. M. Dickfeld, D. A. Bluemke, A. Lardo, R. D. Berger, H. Calkins, and H. R. Halperin
Modern Pacemaker and Implantable Cardioverter/Defibrillator Systems Can Be Magnetic Resonance Imaging Safe: In Vitro and In Vivo Assessment of Safety and Function at 1.5 T
Circulation,
August 3, 2004;
110(5):
475 - 482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Wahl, I. Paetsch, A. Gollesch, S. Roethemeyer, D. Foell, R. Gebker, H. Langreck, C. Klein, E. Fleck, and E. Nagel
Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases
Eur. Heart J.,
July 2, 2004;
25(14):
1230 - 1236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Kanal, J. P. Borgstede, A. J. Barkovich, C. Bell, W. G. Bradley, J. P. Felmlee, J. W. Froelich, E. M. Kaminski, E. K. Keeler, J. W. Lester, et al.
ACR Blue Ribbon Panel Response to the AJR Commentary by Shellock and Crues on the ACR White Paper on MR Safety
Am. J. Roentgenol.,
January 1, 2003;
180(1):
31 - 35.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. F. Rogers
MR Safety: Better Safe Than Sorry
Am. J. Roentgenol.,
June 1, 2002;
178(6):
1311 - 1311.
[Full Text]
[PDF]
|
 |
|